[Malignant humoral hypercalcemia and the parathyroid hormone related protein].
Humoral hypercalcemia in malignant disease results from the production of humoral factors that act on bone to demineralize the skeleton, with subsequent release of calcium. It is characteristic of certain tumours without bony metastases. A recently discovered parathyroid hormone-related protein (PTHrP) has been implicated as a causative hypercalcemic agent. PTHrP exerts its calcium-mobilizing effects by interaction with parathyroid hormone (PTH) receptors in bone and kidney through its amino-terminal sequence, which is homologous with that of PTH. The human PTHrP gene could encode multiple isoforms of the protein due to alternative exon usage. Apart from its involvement in humoral hypercalcemia of malignancy, PTHrP has also been identified in normal tissues, such as keratinocytes and placenta, and is present in high concentration in milk. PTHrP may modulate the calcium homeostasis in some normal physiological conditions, probably acting in a paracrine fashion.
Jemtland
R
R
Institutt for medisinsk biokjemi Universitetet i Oslo.
Rian
E
E
Gautvik
K M
KM
D000595:Amino Acid Sequence; D000917:Antibody Formation; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology* / Q000276:immunology / Q000378:metabolism; D009369:Neoplasms / Q000150:complications* / Q000276:immunology / Q000378:metabolism; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*
C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins
Malignhumoral hyperkalsemi og det parathormonrelaterte protein.